Sep 15, 2026 3-5pm ET
Tuesday on The Robert Scott Bell Show:
Hour 1
Israel, Pfizer Knew COVID Vaccine Caused Fatal Heart Condition – But Waited Months Before Alerting Public Pfizer and Israel’s Ministry of Health had received reports of myocarditis and pericarditis following Pfizer-BioNTech COVID-19 vaccination by early 2021, but information about the emerging safety signal was not broadly communicated to physicians and the public until approximately three to four months later, according to a peer-reviewed study published September 3, 2026, in EXCLI Journal. Researchers Yaakov Ophir and Yaffa Shir-Raz analyzed an internal Israeli Ministry of Health pharmacovigilance dataset containing 531 hospitalization records and 67 unique deaths reported to Pfizer between March 2021 and May 2022. Of 530 hospitalization records containing valid age information, 211, or 39.8%, involved people under 30. Myocarditis or pericarditis appeared in 250 of the 531 hospitalization records, including 151 of the 211 involving patients under 30. Among those younger patients, 134 had no meaningful medical history under the researchers’ definition, and 99 of those 134 had myocarditis or pericarditis, with 90 of the 99 being male. Nine deaths involved people under 50, and myocarditis was recorded in two of those deaths, involving a 22-year-old woman and a 47-year-old man. The researchers reported that Israel had alerted international health authorities about myocarditis cases by late February and early March 2021, while reports to Pfizer began no later than March 25, when a report included 157 hospitalizations and 46 deaths. The study argues that subsequent public communications emphasizing myocarditis as generally rare and mild did not fully convey the case-level patterns contained in the internal data. It also identified revisions and omissions across versions of the Israeli dataset without a documented audit trail explaining every change. Importantly, the dataset consists of pharmacovigilance reports and does not by itself establish that vaccination caused every hospitalization, medical condition or death recorded within it. The researchers’ principal conclusion concerns the timing and completeness of safety-signal communication and its potential consequences for clinical awareness and informed consent during the vaccination campaign.
Study: 24 Drug Pairings Flagged As Risky For Older Adults Twenty-four medication pairings were identified as high-priority potential “prescribing cascades” among older adults in a population-level study involving nearly 2.3 million Ontario residents age 66 and older. A prescribing cascade can occur when a medication produces a side effect that is interpreted as a new medical problem, leading clinicians to prescribe another medication to treat the symptom rather than reconsidering the original drug. Researchers examined 65 potentially inappropriate prescribing cascades previously identified by an international panel of 12 medical specialists from eight countries and analyzed prescription records from 2,297,942 older adults in Ontario. Patients who newly started the first medication between January 2022 and December 2023 were followed to determine whether they began the second medication within one year. Researchers prioritized combinations using several criteria, including how commonly the initial drug was prescribed, how frequently the second medication subsequently appeared and whether the sequence occurred substantially more often in the suspected direction than in reverse. Iron supplements followed by laxatives were the most frequently observed pairing, occurring among 11.9% of relevant patients, consistent with constipation being a recognized effect of iron supplementation. Statins followed by pain medication occurred in 10.9%, while dementia medications followed by sleep medications occurred in 10.3%. The strongest directional signal involved steroids followed by antipsychotic medications, with a sequence ratio of 2.55. Laxatives followed by anti-diarrheal medications produced a ratio of 2.53, while dementia medications followed by anti-nausea drugs had a ratio of 2.24. Researchers emphasize that these patterns do not prove inappropriate prescribing or demonstrate that the first medication caused the condition for which the second was prescribed. Some combinations may be medically appropriate, and administrative health records cannot establish an individual physician’s reason for prescribing a drug. The study instead provides clinicians, pharmacists and healthcare systems with a priority list for medication reviews, encouraging them to consider whether a newly appearing symptom could be an adverse effect of an existing medication before adding another drug. Limitations include the one-year observation window, exclusion of over-the-counter medications, inability to analyze cascades involving more than two drugs and restriction of the population to older adults in Ontario. The findings were published in The BMJ and are intended primarily as a screening framework for identifying potentially avoidable medication cascades rather than a list of drug combinations that patients should automatically discontinue.
Special Guest: Dr. Henry Ealy
Dr. Henry L. Ealy, also known as Dr. Henele or simply Dr. H to his students, is the founder of the Energetic Health Institute (EHI), an educator, author, and longtime practitioner in the field of natural medicine. He founded EHI in 2013 and developed curricula covering Holistic Nutrition, Cleansing & Fasting, vaccine education, and Medical Cannabis. His work is centered on the principle that restoring and supporting the body’s ability to produce energy is fundamental to healing, and he has spent more than 27 years studying, teaching, and developing approaches to natural health and healing.
Dr. Ealy is the author of Energetic Health: Volume 1 (2013), The Book of Questions (2025), and The Philosophy of Healing (2026). According to his EHI biography, he has taught students in settings ranging from universities and clinics to community educational environments, designed comprehensive educational programs, and helped develop practitioners who incorporate nutrition, cleansing, cellular health, and other natural approaches into their work. From 2023 through 2025, he also led the Healing for the A.G.E.S. collaboration involving natural-health practitioners.
Today, Dr. Ealy has returned his primary focus to teaching at the Energetic Health Institute, where his mission is to educate and prepare what he describes as the next generation of healers. His teaching combines natural medicine with an emphasis on energy, frequency, bio-electricity, personal responsibility, compassion, integrity, and what he calls “Love, Logic & Light.” Through EHI, his books, and his continuing educational work, Dr. Ealy remains focused on giving students practical knowledge they can use to better understand their own health and help others pursue their own healing journeys.
The Energetic Health Institute (EHI) began with a powerful vision: to create a school where people could truly learn how to understand health through natural medicine and holistic healthcare. Founded from an idea first envisioned in 1999, EHI was created to bring exceptional teachers together with passionate students who want to make a meaningful difference in the world. Today, that vision continues through an educational community dedicated to creating ripples of healing that extend from individuals to families, communities, and future generations.
At EHI, education is about more than earning a certification – it is about transformation. The Institute’s mission is to empower students to heal what hurts, love unconditionally, discover what life can feel like at their best, and share what they learn for the betterment of others. EHI’s courses and certifications are designed to provide practical, inspiring education from experienced teachers, while creating an environment where students feel supported, valued, and genuinely cared for throughout their journey.
Everything at the Energetic Health Institute is grounded in a culture of compassion, personal growth, dynamic education, solution-oriented thinking, and the belief that Every 1 Matters. EHI believes there is a healer within each of us and that knowledge, shared from the heart, has the power to create healthier people and stronger communities. It’s an invitation to learn, grow, serve, and become part of something bigger – a worldwide community committed To Teach, To Heal, To Love!
At the Energetic Health Institute (EHI), the Aloha Spirit is a guiding principle centered on the coordination of mind and heart. Education is viewed as more than an intellectual pursuit – it is an experience that helps build meaningful relationships, encourages personal growth, and challenges students to become their best selves. EHI emphasizes critical thinking without hostility, personal responsibility, accountability, kindness, humility, and perseverance as essential parts of both learning and healing.
The Aloha Spirit is expressed through five core qualities: kindness, unity, pleasantness, humility, and patience. These values shape how EHI approaches education and community. Students are encouraged to challenge ideas without attacking people, examine systems without losing compassion, and pursue truth without arrogance. EHI describes this balance as one in which knowledge and character develop together, combining intellectual clarity with genuine care for others.
Within the EHI community, people from different backgrounds and perspectives are united not by agreement, but by mutual respect. Thoughtful dialogue, responsible communication, intellectual honesty, and personal accountability are expected, with the Aloha Spirit described as a form of “disciplined kindness.” Ultimately, EHI connects these principles to a larger vision of healing: as individuals make choices to heal and improve themselves, they can create a positive ripple effect that reaches their families, communities, and the people around them.
Hour 2
EXCLUSIVE: The AI Bill Bernie Sanders Introduced Was Drafted in London Sayer Ji reports that the organization ControlAI, a London-based advocacy group, wrote a British bill seeking to prohibit artificial superintelligence and also consulted on the U.S. Ban Artificial Superintelligence Act introduced by Sen. Bernie Sanders and Rep. Greg Casar, a connection acknowledged by ControlAI founder Andrea Miotti in TIME and separately reported by Wired. Ji argues that this outside involvement was not disclosed in Sanders and Casar’s September 3 announcement or in the official record accompanying the British legislation. Sanders and Casar’s proposal would permanently prohibit development and deployment of artificial superintelligence, temporarily pause certain advanced AI development until a new federal regulator establishes safety requirements, create a cabinet-level AI regulatory agency, impose substantial penalties for violations and direct the United States to pursue international agreements intended to prevent development of superintelligence globally. Ji focuses particularly on ControlAI’s funding, identifying Skype co-founder Jaan Tallinn as its only publicly named funder and noting that Tallinn led Anthropic’s Series A financing and has been identified as an observer on Anthropic’s board. Ji then examines language defining covered artificial superintelligence as technology that exhibits, or can “easily be modified” to exhibit, broad human-level or greater capabilities. He argues that this wording could disproportionately affect open-weight AI systems because outside parties can modify them, while closed-weight systems operated by companies such as Anthropic may not be similarly exposed under that particular provision. Ji presents this as a potential structural benefit rather than evidence that Anthropic participated in drafting the legislation. He explicitly states that he is not alleging coordination among ControlAI, Tallinn, Anthropic and the lawmakers, instead arguing that the documented relationships warrant disclosure and further investigation. Ji calls on Sanders and Casar to explain what drafting language or legislative input ControlAI supplied, when those contacts began and whether their offices knew that ControlAI was simultaneously involved with similar British legislation. The central claim supported by the cited reporting is therefore narrower than the headline’s wording might imply: ControlAI wrote the U.K. proposal and acknowledged consulting on the U.S. legislation, while Ji’s broader argument about beneficiaries and undisclosed influence represents his interpretation of those documented relationships.
Antidepressants in Rivers Reach Fish at Levels That Disrupt Their Brain Chemistry, Study Warns Antidepressant concentrations already measured in some polluted waterways overlap with concentrations capable of interfering with serotonin transporter proteins in fish, according to laboratory research published in Environmental Science & Technology. Researchers examined neurotransmitter transporters in medaka and ayu, two fish species evolutionarily distinct from each other and from commonly studied zebrafish, and compared their responses with corresponding human proteins. These transporters regulate serotonin, dopamine and norepinephrine by moving the neurotransmitters back into cells after signaling. Researchers cloned the fish transporter genes, expressed them in laboratory-grown cells and exposed them to different concentrations of antidepressant and psychiatric drugs. The largest species differences involved serotonin transporters. Desipramine, for example, produced 50% inhibition of the human serotonin transporter at approximately 350 nanomolar but reached the same level at approximately 6.1 nanomolar in medaka, 12 nanomolar in ayu and 1.7 nanomolar in zebrafish. Amoxapine likewise affected fish serotonin transporters at substantially lower concentrations than the human equivalent. Researchers also observed unexpected effects from drugs such as mirtazapine and quetiapine, which affected particular fish transporters despite having little or different activity at corresponding human targets. Most significantly for environmental risk, concentrations associated with transporter inhibition overlapped with pharmaceutical concentrations previously detected in contaminated waterways. Duloxetine inhibited the medaka serotonin transporter at a concentration equivalent to roughly 357 nanograms per liter, while corresponding figures were approximately 835 for fluoxetine, 1,233 for citalopram and 1,334 nanograms per liter for paroxetine. The researchers note that actual waterways can contain mixtures of pharmaceuticals, potentially creating combined effects even when individual compounds occur below levels producing strong effects alone. However, the experiment tested isolated transporter proteins in engineered cells rather than exposing living fish, so it does not demonstrate that environmental antidepressant concentrations are currently producing neurological or behavioral damage in wild fish. Live-animal studies examining absorption, metabolism, behavior and mixtures of contaminants are needed to establish the ecological consequences.
40-Year-Old Pennsylvania Woman With ‘Long, Long History’ of Underlying Illnesses Dies After Catching Measles A 40-year-old unvaccinated woman in Jefferson County, Pennsylvania, died September 12 after developing an illness suspected to be measles while already suffering from numerous serious chronic medical conditions, including restrictive lung disease, chronic hypoxemic respiratory failure, COPD, asthma, hypertension and anemia, according to Jefferson County Coroner Greg Furlong. She was dependent on supplemental oxygen 24 hours a day and had experienced major respiratory illnesses for years. The woman had recently been exposed to a neighbor who tested positive for measles and subsequently developed symptoms consistent with measles, including fever, cough, a rash and white spots in her mouth. She was not tested for measles while alive, so a post-mortem nasal specimen was sent to Pennsylvania’s state laboratory for confirmation. Her preliminary death certificate listed respiratory failure associated with suspected measles, COPD and asthma. Furlong said his investigation led him to consider the infection “probable” measles and stated that although the woman’s underlying health was poor, he believed measles contributed substantially to her death and that she likely would not have died at that time without the infection. Whether Pennsylvania ultimately classifies the case as a confirmed measles-associated death depends partly on laboratory confirmation and the state’s case definition. The article places the death within Pennsylvania’s ongoing outbreak, reporting 693 cases as of September 14, including four among vaccinated individuals. It also reviews two earlier infant deaths that generated controversy over how health authorities described measles-associated mortality. One involved a newborn who tested positive for measles but whose autopsy attributed the primary cause of death to a lacerated spleen; another involved a six-week-old infant with Amish lethal microcephaly whom the coroner said died from measles. The article subsequently presents criticism of MMR vaccination from physicians and vaccine-policy critics. Some claims in that portion require important context: reports submitted to VAERS cannot by themselves establish that a vaccine caused a reported illness or death, and extrapolating reported deaths by applying a generalized underreporting multiplier does not establish a true number of vaccine-caused deaths. The immediate Pennsylvania case therefore remains principally a report of a medically fragile woman with suspected measles whose coroner determined that the infection materially contributed to fatal respiratory failure, with laboratory confirmation still pending at publication.
Pennsylvania Health Department Plan to Give Itself More Power Threatens Parents’ Rights, Critics Say Pennsylvania’s Department of Health has proposed a major revision of communicable-disease regulations that would expand reporting requirements and state authority during disease investigations, prompting critics to raise concerns about parental consent, student privacy and the scope of public-health powers. The proposal would increase the number of conditions schools must report from 52 to 125, broaden circumstances under which unvaccinated students could be excluded during outbreaks, require healthcare providers to report vaccinations to Pennsylvania’s immunization information system unless a patient objects in writing, establish a birth-defects registry and expand health officials’ authority to enter locations when necessary for disease investigations. One particularly disputed provision would require schools to provide state or local health officials reasonable access to students for contact tracing or “partner services” and allow officials to speak privately with students without interference by school personnel. Critics argue that when this provision is combined with Pennsylvania law allowing minors under certain circumstances to consent to services involving sexually transmitted or other reportable diseases, it could result in some students receiving hepatitis-related screening or vaccination without advance parental knowledge. The article reports that the proposed regulation itself does not expressly require advance parental notification, parental presence or post-meeting notification for these private encounters. The Department of Health began developing the revisions in 2024 and published them in 2026 for public comment, with comments due September 21. The changes also follow litigation over Pennsylvania’s COVID-era school mask mandate. In 2021, the Pennsylvania Supreme Court ruled that the health department lacked authority under the legal mechanism it had used for the statewide mandate, while the department cites that decision among the reasons for modernizing its regulations. Republican Pennsylvania lawmakers quoted in the article have called for withdrawal or additional legislative oversight of the proposal, including potential sunset requirements for expanded public-health authority. The proposal remains subject to Pennsylvania’s regulatory review process rather than being current law, making the article primarily an account of proposed powers and objections raised by critics rather than changes that have already taken effect.
Wealthy California HOA gives ridiculous excuse for spraying pesticides as rare cancer cluster killing kids tears through community The New York Post article itself could not be accessed through the available web retrieval system, so I cannot produce the required 200-word article-specific summary without risking attributing information to the article that I cannot verify. Independent sources confirm the underlying situation: residents of Ladera Ranch in Orange County have raised concerns about cases of rare childhood cancers, particularly Ewing sarcoma, and some residents have questioned whether pesticide and herbicide applications could be contributing. California’s Department of Public Health says it began a formal cancer-concern assessment in May 2026 using cancer-incidence data through 2023 and expects results in fall 2026. The department explicitly states that it does not yet know whether Ewing sarcoma or other cancers occur more frequently in Ladera Ranch than expected and that pesticides or other chemicals have not been established as the cause. The Department of Pesticide Regulation and Orange County Agricultural Commissioner are separately reviewing local pest-management practices and compliance with state and federal law. Because your standing rules require me to access the submitted article before summarizing it, I don’t want to substitute those outside reports for the New York Post’s actual content. Please paste the New York Post article text here, and I can summarize that final article in the same format.
Remember Friends, The Power to Heal is Yours!
